FDA Approved: OTEZLA — Supplemental Application (Amgen, Inc)

View source ↗

Summary

The FDA approved Amgen's supplemental application for OTEZLA (apremilast), resulting in an approved supplemental change to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Behçet Disease
• Plaque Psoriasis
• Psoriatic Arthritis

Drugs mentioned

• OTEZLA (apremilast)

Snippet

SUPPL AP for OTEZLA (APREMILAST)